2020
$115M
from 6 investors over 6 rounds
SalioGen Therapeutics raised $115M on January 5, 2022
Investors: GordonMD Global Investments LP, T. Rowe Price, EPIQ, RD Fund and D1 Capital Partners L.P.
SalioGen Therapeutics raised $20M on February 18, 2021
Investors: PBM Capital Group